Specialized in GLP-1 analogs and recombinant insulin APIs, delivering end-to-end CDMO solutions from process development to commercial GMP manufacturing for global pharma.
Powered by gene engineering and recombinant protein technologies — dedicated to GLP-1 metabolic drug APIs and large-scale biologics manufacturing for the global pharmaceutical industry.
Cellnuo focuses on biopharmaceutical APIs for metabolic diseases, with flagship products covering GLP-1 analogs such as Semaglutide, Tirzepatide and Liraglutide, plus a full series of recombinant insulin APIs. The company maintains strategic collaborations with leading laboratories in Germany and the United States, providing high-purity, high-stability recombinant proteins, enzymes and cell culture factors with full technical support to global pharma, media manufacturers and research institutions.
From molecular design and process development to pilot scale-up and commercial GMP manufacturing, we deliver one-stop CDMO solutions spanning the entire biologics lifecycle.
Strain construction, media optimization, fermentation development, and downstream purification design — ensuring high purity and batch-to-batch consistency.
Systematic scale-up validation from lab to pilot to commercial — guaranteeing process robustness and seamless GMP transfer.
ICH Q7 compliant API production with electronic batch records, meeting strict quality requirements for IND and NDA filings.
Complete QC system covering physical-chemical analysis, bioactivity testing, impurity profiling and stability studies.
CTD-format DMF/ASMF authoring supporting FDA, EMA and NMPA submissions — accelerating global market entry.
Advanced instrumentation including HPLC, MS, CD spectroscopy supporting protein characterization, activity assays and impurity analysis.
From next-generation peptides to recombinant insulin APIs, bioprocessing enzymes and regenerative biomaterials — engineered to power the next wave of biologics.
Cellnuo operates state-of-the-art GMP API manufacturing facilities equipped with microbial fermenters, chromatography purification systems, and sterile injectable production lines — engineered precisely to deliver the highest quality standard for every batch. Click any video to view full screen.
From candidate molecule to commercial API — transparent, efficient collaboration that accelerates your global registration and launch.
Gene synthesis, vector construction, host selection and high-expression clone screening
Fermentation media optimization, induction studies, cell disruption process design
50L–1000L fermentation scale-up; batch consistency and process robustness validation
ICH Q7 compliant, full electronic batch records, complete quality management system
CTD-format DMF documents supporting FDA/EMA/NMPA registration
Our business team replies within one business day with product quotes, technical data sheets and CDMO collaboration proposals.